Shopping Cart
- Remove All
- Your shopping cart is currently empty
HYNIC-iPSMA TFA serves as a ligand in the molecular imaging of tumors. It comprises HYNIC (6-hydrazinonicotinamide), which is employed to bind radioactive isotopes to target molecules, and iPSMA (Inhibitor of Prostate-Specific Membrane Antigen), a specific inhibitor of PSMA. 68GA-labeled iPSMA is utilized for detecting prostate cancer through PET imaging. Additionally, 99mTc-EDDA/HYNIC-iPSMA TFA exhibits remarkable specificity and sensitivity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | HYNIC-iPSMA TFA serves as a ligand in the molecular imaging of tumors. It comprises HYNIC (6-hydrazinonicotinamide), which is employed to bind radioactive isotopes to target molecules, and iPSMA (Inhibitor of Prostate-Specific Membrane Antigen), a specific inhibitor of PSMA. 68GA-labeled iPSMA is utilized for detecting prostate cancer through PET imaging. Additionally, 99mTc-EDDA/HYNIC-iPSMA TFA exhibits remarkable specificity and sensitivity. |
Molecular Weight | 765.69 |
Formula | C33H38F3N7O11 |
Cas No. | 2375849-11-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.